74 related articles for article (PubMed ID: 30334007)
1. Impact of the COVID-19 pandemic on diagnosis of renal cell carcinoma and disease stage at presentation.
Janes WCI; Fagan MG; Andrews JM; Harvey DR; Warden GM; Johnston PH; Organ MK
Can Urol Assoc J; 2024 Apr; 18(4):E113-E119. PubMed ID: 38381938
[TBL] [Abstract][Full Text] [Related]
2. Renal Cell Carcinoma Update: News from the AUA, EAU, and ASCO Annual Meetings 2011.
Schrader AJ; Steffens S
ISRN Urol; 2012; 2012():748235. PubMed ID: 22779004
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and Trends of Drinking Water Disinfection Byproducts-Related Cancers in Addis Ababa, Ethiopia.
Tafesse N; Porcelli M; Gari SR; Ambelu A
Environ Health Insights; 2022; 16():11786302221112569. PubMed ID: 35910284
[TBL] [Abstract][Full Text] [Related]
4. Kidney cancer mortality disparities among Hispanics in the US.
Pinheiro PS; Medina HN; Callahan KE; Koru-Sengul T; Sharma J; Kobetz EN; Penedo FJ
Cancer Epidemiol; 2021 Jun; 72():101938. PubMed ID: 33862414
[TBL] [Abstract][Full Text] [Related]
5. Association of Prevalence of Benign Pathologic Findings After Partial Nephrectomy With Preoperative Imaging Patterns in the United States From 2007 to 2014.
Kim JH; Li S; Khandwala Y; Chung KJ; Park HK; Chung BI
JAMA Surg; 2019 Mar; 154(3):225-231. PubMed ID: 30516801
[TBL] [Abstract][Full Text] [Related]
6. National trends of preoperative imaging modalities before partial nephrectomy for renal masses in the U.S. from 2007-2015.
Kim JH; Li S; Khandwala Y; Del Giudice F; Chung KJ; Park HK; Chung BI
Can Urol Assoc J; 2019 Mar; 13(3):E89-E94. PubMed ID: 30169151
[TBL] [Abstract][Full Text] [Related]
7. Body mass index and the clinicopathological characteristics of clinically localized renal masses-An international retrospective review.
Tsivian E; Tsivian M; Tay KJ; Longo T; Zukerman Z; Martorana G; Schiavina R; Brunocilla E; Polascik TJ
Urol Oncol; 2017 Jul; 35(7):459.e1-459.e5. PubMed ID: 28284892
[TBL] [Abstract][Full Text] [Related]
8. Kidney Cancer Incidence in California: End of the Trend?
Morris CR; Lara PN; Parikh-Patel A; Kizer KW
Kidney Cancer; 2017 Jul; 1(1):71-81. PubMed ID: 30334007
[No Abstract] [Full Text] [Related]
9. Clinical Stage Migration and Survival for Renal Cell Carcinoma in the United States.
Patel HD; Gupta M; Joice GA; Srivastava A; Alam R; Allaf ME; Pierorazio PM
Eur Urol Oncol; 2019 Jul; 2(4):343-348. PubMed ID: 31277771
[TBL] [Abstract][Full Text] [Related]
10. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
11. Renal cell carcinoma trends in Latvia: incidence, mortality, and survival rates. Population-based study.
Jakubovskis M; Kojalo U; Steinbrekera B; Auziņš J; Kirilovas D; Lietuvietis V
Cent European J Urol; 2019; 72(4):344-350. PubMed ID: 32015902
[TBL] [Abstract][Full Text] [Related]
12. Contemporary incidence and mortality rates of kidney cancer in the United States.
Gandaglia G; Ravi P; Abdollah F; Abd-El-Barr AE; Becker A; Popa I; Briganti A; Karakiewicz PI; Trinh QD; Jewett MA; Sun M
Can Urol Assoc J; 2014 Jul; 8(7-8):247-52. PubMed ID: 25210548
[TBL] [Abstract][Full Text] [Related]
13. Pathological High-risk Renal Cell Carcinoma: Trends in Clinical Characteristics Over 25 Years.
DI Trapani E; Dell'oglio P; Larcher A; Nini A; Muttin F; Cianflone F; Dehò F; Matloob R; DI Trapani D; Freschi M; Salonia A; Briganti A; Montorsi F; Bertini R; Capitanio U
Anticancer Res; 2018 Jul; 38(7):4123-4130. PubMed ID: 29970539
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]